$2125 | SAVE $375 | Single User
$4250 | SAVE $750 | Site License
$6375 | SAVE $1,125 | Enterprise License

Seasonal Influenza Global Clinical Trials Review, H2, 2015
[Published by Global Data]

Published by Global Data: 30 Dec 2015 | 17922 | In Stock
Related Topics: Clinical Trials

Introduction

Seasonal Influenza Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Seasonal Influenza Global Clinical Trials Review, H2, 2015" provides an overview of Seasonal Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on Seasonal Influenza. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Seasonal Influenza Global Clinical Trials Review, H2, 2015 [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

    Top Five Countries Contributing to Clinical Trials in Europe 11

    Top Countries Contributing to Clinical Trials in North America 12

    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

    Top Five Countries Contributing to Clinical Trials in Central and South America 14

    Clinical Trials by G7 Countries: Proportion of Seasonal Influenza to Infectious Disease Clinical Trials 15

    Clinical Trials by Phase in G7 Countries 16

    Clinical Trials in G7 Countries by Trial Status 17

    Clinical Trials by E7 Countries: Proportion of Seasonal Influenza to Infectious Disease Clinical Trials 18

    Clinical Trials by Phase in E7 Countries 19

    Clinical Trials in E7 Countries by Trial Status 20

    Clinical Trials by Phase 21

    In Progress Trials by Phase 22

    Clinical Trials by Trial Status 23

    Clinical Trials by End Point Status 24

    Subjects Recruited Over a Period of Time 25

    Clinical Trials by Sponsor Type 26

    Prominent Sponsors 27

    Top Companies Participating in Seasonal Influenza Therapeutics Clinical Trials 28

    Prominent Drugs 30

    Latest Clinical Trials News on Seasonal Influenza 31

    Oct 21, 2015: BiondVax Announces Successful Recruitment of the First Participants in a Phase IIb Clinical Trial in Europe with its Universal Flu Vaccine: Multimeric M-001 31

    Oct 05, 2015: Visterra’s Monoclonal Antibody in Development for the Treatment of Influenza A, VIS410, Demonstrated Significant Antiviral Activity and Reduced Duration of Respiratory Symptoms in Phase 2a Challenge Study 31

    Clinical Trial Profile Snapshots 33

    Appendix 104

    Abbreviations 104

    Definitions 104

    Research Methodology 105

    Secondary Research 105

    About GlobalData 106

    Contact Us 106

    Disclaimer 106

    Source 107

List Of Tables
in Seasonal Influenza Global Clinical Trials Review, H2, 2015 [Published by Global Data]

List of Tables

Seasonal Influenza Therapeutics, Global, Clinical Trials by Region, 2015* 6

Seasonal Influenza Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Seasonal Influenza Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Seasonal Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Seasonal Influenza Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Seasonal Influenza Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Seasonal Influenza Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Seasonal Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Seasonal Influenza to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Seasonal Influenza Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Seasonal Influenza Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Seasonal Influenza to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Seasonal Influenza Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Seasonal Influenza Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Seasonal Influenza Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Seasonal Influenza Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Seasonal Influenza Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Seasonal Influenza Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Seasonal Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Seasonal Influenza Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26

Seasonal Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Seasonal Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Seasonal Influenza Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

List Of Figures, Charts and Diagrams
in Seasonal Influenza Global Clinical Trials Review, H2, 2015 [Published by Global Data]

List of Figures

Seasonal Influenza Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Seasonal Influenza Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Seasonal Influenza Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Seasonal Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Seasonal Influenza Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Seasonal Influenza Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Seasonal Influenza Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Seasonal Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Seasonal Influenza to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Seasonal Influenza Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Seasonal Influenza Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Seasonal Influenza to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Seasonal Influenza Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Seasonal Influenza Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Seasonal Influenza Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Seasonal Influenza Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Seasonal Influenza Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Seasonal Influenza Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Seasonal Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Seasonal Influenza Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26

Seasonal Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Seasonal Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28

Seasonal Influenza Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 105

Additional Details

Publisher

Global Data

Publisher Information

Reference

17922 | GDHC3165CTIDB

Number of Pages

107

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Seasonal Influenza: Competitive Landscape to 2026
Seasonal Influenza: Competitive Landscape to 2026SummaryInfluenza, often referred to as the flu, is ...
08 Nov 2018 by Global Data USD $2,971 (normally
USD $3,495)
More Info
SAVE 15% today! Seasonal Influenza Vaccine Market Size, Country Outlook, Vaccination Analysis, Pipeline Insights, Clinical Trials Statement, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022
Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven majo...
21 Nov 2016 by DPI Research USD $1,700 (normally
USD $2,000)
More Info
SAVE 15% today! EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025
EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025SummaryInfluenza, commonly known a...
01 Nov 2016 by Global Data USD $3,396 (normally
USD $3,995)
More Info
SAVE 15% today! EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025
EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025SummaryInfluenza, commonly known a...
01 Nov 2016 by Global Data USD $3,396 (normally
USD $3,995)
More Info
SAVE 15% today! PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2025
PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2025SummaryIn...
01 Nov 2016 by Global Data USD $9,346 (normally
USD $10,995)
More Info
SAVE 15% today! Seasonal Influenza Vaccines - US Drug Forecast and Market Analysis to 2025
Seasonal Influenza Vaccines - US Drug Forecast and Market Analysis to 2025SummaryInfluenza, often re...
01 Nov 2016 by Global Data USD $4,246 (normally
USD $4,995)
More Info
SAVE 15% today! Seasonal Influenza Vaccines - Japan Drug Forecast and Market Analysis to 2025
Seasonal Influenza Vaccines - Japan Drug Forecast and Market Analysis to 2025SummaryInfluenza, often...
01 Nov 2016 by Global Data USD $4,246 (normally
USD $4,995)
More Info
SAVE 15% today! Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2016
Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial...
30 Sep 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016
Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinica...
27 Jul 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016
Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinica...
27 Jul 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Seasonal Influenza Global Clinical Trials Review, H2, 2015 [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...